Space F (Biotechnology) Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$15M
- Investors
-
8
Space F (Biotechnology) General Information
Description
Developer of cell farming technology intended to provide meat alternative food products. The company's technology uses stem cell and tissue engineering techniques to extract and cultivate animal cells to make livestock substitutes, enabling customers to get sustainable and safe alternative food items.
Contact Information
Website
spacef.bizCorporate Office
- 806 The First Tower
- 10 Dongtan-daero 21-gil, Gyeonggi-do
- Hwaseong, 18471
- South Korea
Corporate Office
- 806 The First Tower
- 10 Dongtan-daero 21-gil, Gyeonggi-do
- Hwaseong, 18471
- South Korea
Space F (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 05-May-2022 | $15M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 25-Aug-2021 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Apr-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Space F (Biotechnology) Patents
Space F (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250129331-A1 | Medium composition for culture of extraembryonic endoderm stem cells | Pending | 23-Feb-2023 | ||
| WO-2024177208-A1 | Medium composition for culture of extraembryonic endoderm stem cells | Inactive | 23-Feb-2023 | ||
| EP-4495229-A1 | Medium composition for culturing porcine pluripotent stem cells | Pending | 14-Mar-2022 | ||
| EP-4495229-A4 | Medium composition for culturing porcine pluripotent stem cells | Pending | 14-Mar-2022 | ||
| US-20250051724-A1 | Medium composition for culturing porcine pluripotent stem cells | Pending | 14-Mar-2022 | C12N5/0606 |
Space F (Biotechnology) Signals
Space F (Biotechnology) Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ministry of Trade, Industry and Resources | Limited Partner | Minority | ||
| CJ Investment | Corporate Venture Capital | Minority | ||
| Daesang | Corporation | Minority | ||
| DAYLI Partners | Venture Capital | Minority | ||
| Lotte Ventures | Corporate Venture Capital | Minority |
Space F (Biotechnology) FAQs
-
When was Space F (Biotechnology) founded?
Space F (Biotechnology) was founded in 2020.
-
Where is Space F (Biotechnology) headquartered?
Space F (Biotechnology) is headquartered in Hwaseong, South Korea.
-
What is the size of Space F (Biotechnology)?
Space F (Biotechnology) has 18 total employees.
-
What industry is Space F (Biotechnology) in?
Space F (Biotechnology)’s primary industry is Biotechnology.
-
Is Space F (Biotechnology) a private or public company?
Space F (Biotechnology) is a Private company.
-
What is Space F (Biotechnology)’s current revenue?
The current revenue for Space F (Biotechnology) is .
-
How much funding has Space F (Biotechnology) raised over time?
Space F (Biotechnology) has raised $6.04M.
-
Who are Space F (Biotechnology)’s investors?
Ministry of Trade, Industry and Resources, CJ Investment, Daesang, DAYLI Partners, and Lotte Ventures are 5 of 8 investors who have invested in Space F (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process